A sensitive radioimmunoassay and an antibody class-specific enzyme-linked immunosorbent assay were used to determine whether patients cured of cryptococcosis responded normally to immunization with cryptococcal capsular polysaccharide (CPS) and type III pneumococcal polysaccharide. 10 normal volunteers and 8 patients who had been cured of cryptococcal meningitis and who had been cured of cryptococcal meningitis and who had no serious underlying diseases were immunized with both antigens. Geometric mean titers to CPS measured by radioimmunoassay were 1:1 in both groups before vaccination, but were 1:3 in patients and 1:119 in controls following immunization (P less than 0.01, Student's t test). Analysis of the class-specific response to immunization with CPS found little anti-CPS IgG or IgA. Geometric mean postvaccination IgM titers were 1:31 in patients and 1:238 in controls (P less than 0.01). Responses to immunization with type III pneumococcal polysaccharide were similar in patients and controls, with IgA, IgM, and IgG mean titers of 1:1129, 1:369, and 1:158 in patients and 1:1504, 1:1039, and 1:163 in controls (P greater than 0.2 for each antibody class). Cured cryptococcal meningitis is often associated with prolonged specific immunologic unresponsiveness.
D K Henderson, J E Bennett, M A Huber
Title and authors | Publication | Year |
---|---|---|
The Cu regulon of the human fungal pathogen Cryptococcus neoformans H99: Cuf1 activates distinct genes in response to both Cu excess and deficiency
C Ding, J Yin, EM Tovar, DA Fitzpatrick, DG Higgins, DJ Thiele |
Molecular Microbiology | 2011 |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
VG Fowler, WM Scheld, AS Bayer |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases | 2010 |
National Institute of Allergy and Infectious Diseases, NIH
VS Georgiev |
2010 | |
Cryptococcus: From Human Pathogen to Model Yeast
J Heitman, TR Kozel, KJ Kwon-Chung, JR Perfect, A Casadevall |
2010 | |
Fungal Infections
Chimelli L, Mahler\u2010Araújo MB |
Brain Pathology | 2008 |
Immunology of Fungal Infections
GD Brown, MG Netea |
2007 | |
Molecular Principles of Fungal Pathogenesis
J Heitman, SG Filler, JE Edwards, AP Mitchell |
2006 | |
Effect of Amphotericin B on Capsule and Cell Size in Cryptococcus neoformans during Murine Infection
O Zaragoza, C Mihu, A Casadevall, JD Nosanchuk |
Antimicrobial agents and chemotherapy | 2005 |
Cryptococcose
F Dromer, O Lortholary |
EMC - Maladies Infectieuses | 2004 |
Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis
W He, A Casadevall, SC Lee, DL Goldman |
Infection and immunity | 2003 |
Cyclic AMP-Dependent Protein Kinase Controls Virulence of the Fungal Pathogen Cryptococcus neoformans
CA D'Souza, JA Alspaugh, C Yue, T Harashima, GM Cox, JR Perfect, J Heitman |
Molecular and cellular biology | 2001 |
Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection
R Malik, BR Speed, J Kaldor, B Cairns, M Pegorer, DI Wigney, DN Love |
Medical Mycology | 1999 |
Serum antibody response toCryptococcus neoformansin cats, dogs and koalas with and without active infection
R Malik, BR Speed, J Kaldor, B Cairns, M Pegorer, DI Wigney, DN Love |
Medical Mycology | 1999 |
Epidemiological evidence for dormant Cryptococcus neoformans infection
D Garcia-Hermoso, G Janbon, F Dromer |
Journal of clinical microbiology | 1999 |
Epidemiological Evidence for Dormant Cryptococcus neoformans Infection
D Garcia-Hermoso, G Janbon, F Dromer |
Journal of clinical microbiology | 1999 |
What makes Cryptococcus neoformans a pathogen?
KL Buchanan, JW Murphy |
Emerging infectious diseases | 1998 |
Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity
A Vecchiarelli, A Casadevall |
Research in Immunology | 1998 |
Cryptococcus neoformans
A Casadevall, JR Perfect |
1998 | |
Fungal Infections
L Chimelli, MB Mahler-Araújo |
Brain Pathology | 1997 |
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis
AC Savoy, DM Lupan, PB Manalo, JS Roberts, AM Schlageter, LC Weinhold, TR Kozel |
Infection and immunity | 1997 |
Serum antibody response to active infection withCryptococcus neoformansand its varieties in immunocompetent subjects
BR Speed, J Kaldor, B Cairns, M Pegorer |
Medical Mycology | 1996 |
Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis
SC Lee, A Casadevall, DW Dickson |
The American Journal of Pathology | 1996 |
Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?
LA Pirofski, A Casadevall |
Zentralblatt für Bakteriologie | 1996 |
Exposure to Cryptococcus neoformans var. gattii — a seroepidemiological study
RA Seaton, AJ Hamilton, RJ Hay, DA Warrell |
Transactions of the Royal Society of Tropical Medicine and Hygiene | 1996 |
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV− individuals
M Deshaw, LA Pirofski |
Clinical & Experimental Immunology | 1995 |
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
TG Mitchell, JR Perfect |
Clinical microbiology reviews | 1995 |
Antibody immunity and invasive fungal infections
A Casadevall |
Infection and immunity | 1995 |
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals
M Deshaw, LA Pirofski |
Clinical & Experimental Immunology | 1995 |
Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody
DL Goldman, SC Lee, A Casadevall |
Infection and immunity | 1995 |
Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine
L Pirofski, R Lui, M DeShaw, AB Kressel, Z Zhong |
Infection and immunity | 1995 |
Anti-Cryptococcus neoformans antibodies during cryptococcosis in patients with the acquired immunodeficiency syndrome
F Dromer, DW Denning, DA StevenS, A Noble, JR Hamilton |
Serodiagnosis and Immunotherapy in Infectious Disease | 1995 |
Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan
DC Houpt, GS Pfrommer, BJ Young, TA Larson, TR Kozel |
Infection and immunity | 1994 |
Fungal Infections and Immune Responses
JW Murphy, H Friedman, M Bendinelli |
1993 | |
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes
MF Miller, TG Mitchell |
Infection and immunity | 1991 |
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity
SJ Devi, R Schneerson, W Egan, TJ Ulrich, D Bryla, JB Robbins, JE Bennett |
Infection and immunity | 1991 |
Fungal Cell Wall and Immune Response
JP Latgé, D Boucias |
1991 | |
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody
MF Miller, TG Mitchell, WJ Storkus, JR Dawson |
Infection and immunity | 1990 |
Current concepts in Cryptococcosis
TF Patterson, VT Andriole |
European Journal of Clinical Microbiology & Infectious Diseases | 1989 |
Candida Cell Wall Mannan: A Polysaccharide with Diverse Immunologic Properties
JE Domer |
Critical Reviews in Microbiology | 1989 |
Cryptococcosis
JR Perfect |
Infectious Disease Clinics of North America | 1989 |
Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice
F Dromer, P Yeni, J Charreire |
Immunogenetics | 1988 |
Cryptococcal meningitis presenting as uveitis
SP Stone, J Bendig, J Hakim, PE Kinnear, BS Azadian, F Clifford-Rose |
The British journal of ophthalmology | 1988 |
Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody
F Dromer, J Charreire, A Contrepois, C Carbon, P Yeni |
Infection and immunity | 1987 |
Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide
F Dromer, J Salamero, A Contrepois, C Carbon, P Yeni |
Infection and immunity | 1987 |
Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro
DK Henderson, VL Kan, JE Bennett |
Clinical & Experimental Immunology | 1986 |
Immunology of fungal infections in animals
PF Lehmann |
Veterinary Immunology and Immunopathology | 1985 |
Selective Antibody Deficiency and Recurrent Pneumococcal Bacteremia in a Patient with Sjögren's Syndrome, Hyperimmunoglobulinemia G, and Deficiencies of IgG2 and IgG4
L Matter, JA Wilhelm, W Angehrn, F Skvaril, K Schopfer |
New England Journal of Medicine | 1985 |